Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078985232> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W2078985232 endingPage "866" @default.
- W2078985232 startingPage "860" @default.
- W2078985232 abstract "The effectiveness of intravitreal triamcinolone acetonide in the treatment of cystoid macular edema from central retinal vein occlusion (CRVO) was investigated.A noncomparative, prospective, interventional case series.In a clinical practice, 18 patients were enrolled with nonischemic CRVO and cystoid macular edema. Two milligrams of triamcinolone acetonide were injected into the vitreous of only one eye from each patient. The outcome measures were 1-mm mean central retinal thickness on optical coherence tomography and visual acuity.Mean duration of symptoms before surgery was 2 months (SD, 1.3 months). Ten patients required repeated injections for recurrent cystoid macular edema (mean, 1.8 injections). Mean visual acuity significantly improved from 20/300 to 20/166 (P = .007) at 1 month, 20/100 (P = .0005) at 2 months, 20/130 (P = .007) at 3 months, and 20/150 (P = .02) at 6 months but deteriorated again to 20/270 (not significant) at 12 months. There was a significant improvement in retinal thickness from presentation 518 microm, to 363 microm (P = .03) at 1 month, 304 microm (P = .04) at 2 months, and 353 microm (P = .01) at 3 months but not from presentation at 6 months (mean, 383 microm) and 12 months (mean, 406 microm). Eleven patients suffered intraocular pressure rises requiring intervention. Intravitreal triamcinolone acetonide did not prevent collateral circulation formation, which was seen in 10 patients.Intravitreal corticosteroid injection is very effective in reversing cystoid macular edema and improving visual acuity in recent-onset nonischemic CRVO in the first 6 months, but this is unfortunately not sustained at 1 year." @default.
- W2078985232 created "2016-06-24" @default.
- W2078985232 creator A5009523037 @default.
- W2078985232 creator A5081153880 @default.
- W2078985232 date "2005-05-01" @default.
- W2078985232 modified "2023-10-16" @default.
- W2078985232 title "Intravitreal Triamcinolone Acetonide for Cystoid Macular Edema in Nonischemic Central Retinal Vein Occlusion" @default.
- W2078985232 cites W115924114 @default.
- W2078985232 cites W1984894729 @default.
- W2078985232 cites W1998806479 @default.
- W2078985232 cites W2015033282 @default.
- W2078985232 cites W2019926635 @default.
- W2078985232 cites W2038454683 @default.
- W2078985232 cites W2048518851 @default.
- W2078985232 cites W2061463978 @default.
- W2078985232 cites W2064353444 @default.
- W2078985232 cites W2069421922 @default.
- W2078985232 cites W2080702909 @default.
- W2078985232 cites W2083092631 @default.
- W2078985232 cites W2087355096 @default.
- W2078985232 cites W2087494096 @default.
- W2078985232 cites W2110175853 @default.
- W2078985232 cites W2122512817 @default.
- W2078985232 cites W2135333970 @default.
- W2078985232 cites W2149187593 @default.
- W2078985232 cites W2152756593 @default.
- W2078985232 cites W2546961712 @default.
- W2078985232 cites W4235001346 @default.
- W2078985232 doi "https://doi.org/10.1016/j.ajo.2005.01.001" @default.
- W2078985232 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15860292" @default.
- W2078985232 hasPublicationYear "2005" @default.
- W2078985232 type Work @default.
- W2078985232 sameAs 2078985232 @default.
- W2078985232 citedByCount "97" @default.
- W2078985232 countsByYear W20789852322012 @default.
- W2078985232 countsByYear W20789852322013 @default.
- W2078985232 countsByYear W20789852322014 @default.
- W2078985232 countsByYear W20789852322015 @default.
- W2078985232 countsByYear W20789852322016 @default.
- W2078985232 countsByYear W20789852322017 @default.
- W2078985232 countsByYear W20789852322018 @default.
- W2078985232 countsByYear W20789852322019 @default.
- W2078985232 countsByYear W20789852322021 @default.
- W2078985232 crossrefType "journal-article" @default.
- W2078985232 hasAuthorship W2078985232A5009523037 @default.
- W2078985232 hasAuthorship W2078985232A5081153880 @default.
- W2078985232 hasConcept C118487528 @default.
- W2078985232 hasConcept C141071460 @default.
- W2078985232 hasConcept C2776251621 @default.
- W2078985232 hasConcept C2778257484 @default.
- W2078985232 hasConcept C2778844676 @default.
- W2078985232 hasConcept C2778903070 @default.
- W2078985232 hasConcept C2780347916 @default.
- W2078985232 hasConcept C2781092963 @default.
- W2078985232 hasConcept C71924100 @default.
- W2078985232 hasConceptScore W2078985232C118487528 @default.
- W2078985232 hasConceptScore W2078985232C141071460 @default.
- W2078985232 hasConceptScore W2078985232C2776251621 @default.
- W2078985232 hasConceptScore W2078985232C2778257484 @default.
- W2078985232 hasConceptScore W2078985232C2778844676 @default.
- W2078985232 hasConceptScore W2078985232C2778903070 @default.
- W2078985232 hasConceptScore W2078985232C2780347916 @default.
- W2078985232 hasConceptScore W2078985232C2781092963 @default.
- W2078985232 hasConceptScore W2078985232C71924100 @default.
- W2078985232 hasIssue "5" @default.
- W2078985232 hasLocation W20789852321 @default.
- W2078985232 hasLocation W20789852322 @default.
- W2078985232 hasOpenAccess W2078985232 @default.
- W2078985232 hasPrimaryLocation W20789852321 @default.
- W2078985232 hasRelatedWork W2017425399 @default.
- W2078985232 hasRelatedWork W2023613318 @default.
- W2078985232 hasRelatedWork W2063375359 @default.
- W2078985232 hasRelatedWork W2353997556 @default.
- W2078985232 hasRelatedWork W2367705216 @default.
- W2078985232 hasRelatedWork W2385736929 @default.
- W2078985232 hasRelatedWork W2743295439 @default.
- W2078985232 hasRelatedWork W3211987817 @default.
- W2078985232 hasRelatedWork W4224762131 @default.
- W2078985232 hasRelatedWork W3032766120 @default.
- W2078985232 hasVolume "139" @default.
- W2078985232 isParatext "false" @default.
- W2078985232 isRetracted "false" @default.
- W2078985232 magId "2078985232" @default.
- W2078985232 workType "article" @default.